IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
71.76
+0.52 (0.73%)
At close: Oct 6, 2025, 4:00 PM EDT
70.37
-1.39 (-1.94%)
After-hours: Oct 6, 2025, 4:27 PM EDT
IRADIMED CORPORATION Market Cap
IRADIMED CORPORATION has a market cap or net worth of $912.79 million as of October 6, 2025. Its market cap has increased by 48.69% in one year.
Market Cap
912.79M
Enterprise Value
859.79M
1-Year Change
48.69%
Ranking
Category
Stock Price
$71.76
Market Cap Chart
Since July 16, 2014, IRADIMED CORPORATION's market cap has increased from $100.50M to $912.79M, an increase of 808.25%. That is a compound annual growth rate of 21.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 906.20M | 30.01% |
| Dec 31, 2024 | 697.00M | 16.48% |
| Dec 29, 2023 | 598.40M | 68.33% |
| Dec 30, 2022 | 355.50M | -37.66% |
| Dec 31, 2021 | 570.30M | 103.90% |
| Dec 31, 2020 | 279.70M | 4.17% |
| Dec 31, 2019 | 268.50M | 0.37% |
| Dec 31, 2018 | 267.50M | 67.29% |
| Dec 29, 2017 | 159.90M | 34.48% |
| Dec 30, 2016 | 118.90M | -61.68% |
| Dec 31, 2015 | 310.30M | 122.44% |
| Dec 31, 2014 | 139.50M | 38.81% |
| Jul 16, 2014 | 100.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |